Which antibiotic is listed as a first-line option for UTIs?

Study for the Clinical Approach to Common Infections Test. Prepare using flashcards and multiple-choice questions, all with hints and explanations. Ace your exam!

Multiple Choice

Which antibiotic is listed as a first-line option for UTIs?

Explanation:
First-line therapy for UTIs hinges on choosing an agent that achieves good concentrations in the urine and reliably covers the common uropathogens, primarily E. coli. Amoxicillin-clavulanate provides beta-lactamase coverage and reaches useful urinary levels, making it a reasonable first-line choice in some practice patterns. The other options are less suitable for uncomplicated UTIs: doxycycline has limited activity against typical Gram-negative uropathogens and inconsistent urinary concentrations; azithromycin isn’t active against the main urinary pathogens and doesn’t achieve reliable bladder levels; clindamycin has poor activity against Gram-negative rods and inadequate urinary penetration. So, among the options listed, amoxicillin-clavulanate best fits the concept of a first-line agent in certain guidelines, even though many current guidelines favor nitrofurantoin, TMP-SMX, or fosfomycin as preferred first-line therapies.

First-line therapy for UTIs hinges on choosing an agent that achieves good concentrations in the urine and reliably covers the common uropathogens, primarily E. coli. Amoxicillin-clavulanate provides beta-lactamase coverage and reaches useful urinary levels, making it a reasonable first-line choice in some practice patterns. The other options are less suitable for uncomplicated UTIs: doxycycline has limited activity against typical Gram-negative uropathogens and inconsistent urinary concentrations; azithromycin isn’t active against the main urinary pathogens and doesn’t achieve reliable bladder levels; clindamycin has poor activity against Gram-negative rods and inadequate urinary penetration. So, among the options listed, amoxicillin-clavulanate best fits the concept of a first-line agent in certain guidelines, even though many current guidelines favor nitrofurantoin, TMP-SMX, or fosfomycin as preferred first-line therapies.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy